Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 27556
Event :Microbiome Therapeutics US

Dates :Wednesday September 05th, 2018 - Thursday September 06th, 2018

Location :Hynes Convention Center
900 Boylston Street
02115 Boston, United States

Type :Conference & Seminar - International audience

Accreditation :--


 

Further information

 

Microbiome Therapeutics US brings together leading experts from across the human microbiome therapeutics field to explore the latest progress in finding the most effective route from microbiome drug discovery through to commercial success. 
 
The meeting provides the ultimate platform to get involved in the latest discussions with like-minded professionals surrounding the latest clinical trials, manufacturing and scale-up challenges, funding solutions and commercialization strategies to take these products to market.
 
Join the likes of Flagship Pioneering, Siolta Therapeutics, Finch Therapeutics and many more to benchmark your end-to-end microbiome drug strategy with practical industry insights, case studies, shared experiences and lessons learned to help you stay ahead of the curve.
 
Plus, ensure you're up to date with the latest regulatory guidance with direct feedback from the FDA and seek out funding opportunities to take your pipeline to the next level.
 
 
Prices:
Industry - For Pharma, Biotech,  Microbiome Therapeutics and Supplier, Vendor, Consultant, Technology Provider Companies: USD 1699.0
Academic: USD 850.0
 
Speakers: Julia Barrett, Senior Clinical Consultant at Biologics Consulting, Keith Batchelder, MD, CEO and Founder at Genomic Healthcare Strategies, JP Benya, VP, Commercial at Assembly Biosciences, David Berry, Partner at Flagship Pioneering, Rodolphe Clerval, CBO at Enterome, David Donabedian, PhD, CEO, Co-Founder at Axial Biotherapeutics, Akintunde Emiola, PhD, PostDoctoral associate at The Jackson Laboratory, Michalis Hadjithomas, Microbiome Lead Scientist at DNANexus, Zain Kassam, MD, co-founder and Executive VP at Finch Therapeutics, Nikole Kimes, PhD, Founder and Chief Scientific Officer at Siolta Therapeutics, David Kyle, CEO at Evolve BioSystems Inc, Robert Langer, SCD, David H. Koch Institute Professor at Massachusetts Institute of Technology, Mark Smith, CEO at Finch Therapeutics, Erik Spek, PhD, Vice President, Head of Intellectual Property at Vedanta Biosciences, Inc., Lily Ting, PhD, Head of RandD at Commense, Kamal Velmurugan, Microbiologist, Primary Reviewer at FDA, James Weston, MBA, Senior Vice President of Regulatory Affairs at Seres Therapeutics
 
Time: 8:00 am - 6:30 pm

Location

Map and directions
Conference address :
Hynes Convention Center
900 Boylston Street
02115 Boston
United States
Map and directions

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama

Details

Microbiome Therapeutics US Pharmacy
drug discovery
Everyone
-- -- --
English

Other

For more information on Microbiome Therapeutics US, plsase contactr KNect365 Life Sciences

To display announcer website, obtain a letter of invitation, you must be logged

Log to my account
Register on Doctorama


Recommend this event